Patents by Inventor Cesar V. Borlongan

Cesar V. Borlongan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11351202
    Abstract: The invention relates to the treatment of various injuries, disorders, dysfunctions, diseases, and the like of the brain with MAPCs, particularly in some aspects, to the treatment of the same resulting from hypoxia, including that caused by systemic hypoxia and that caused by insufficient blood supply. In some further particulars the invention relates, for example, to the treatment of hypoxic ischemic brain injury with MAPCs, in children for example, and to the treatment of cortical infarcts and stroke with MAPCs in adults, for example.
    Type: Grant
    Filed: December 20, 2017
    Date of Patent: June 7, 2022
    Assignees: ABT HOLDING COMPANY, AUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC.
    Inventors: Robert Mays, Robert J. Deans, David C. Hess, James E. Carroll, Cesar V. Borlongan
  • Publication number: 20220118026
    Abstract: The invention relates to the treatment of various injuries, disorders, dysfunctions, diseases, and the like of the brain with MAPCs, particularly in some aspects, to the treatment of the same resulting from hypoxia, including that caused by systemic hypoxia and that caused by insufficient blood supply. In some further particulars the invention relates, for example, to the treatment of hypoxic ischemic brain injury with MPACs, in children, for example, and to the treatment of cortical infarcts and stroke with MAPCs in adults, for example.
    Type: Application
    Filed: December 20, 2021
    Publication date: April 21, 2022
    Applicants: ABT Holding Company, AUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC.
    Inventors: Robert MAYS, Robert J. DEANS, David C. HESS, James E. CARROLL, Cesar V. BORLONGAN
  • Publication number: 20220110982
    Abstract: The invention relates to the treatment of various injuries, disorders, dysfunctions, diseases, and like of the brain with MAPCs, particularly in some aspects, to the treatment of the same resulting from hypoxia, including that caused by systemic hypoxis and that caused by insufficient blood supply. In some further particulars the invntion relates, for example, to the treatment of hypoxic ischemic brain injury with MAPCs, in children, for example, and to the treatment of cortical infants and stroke with MAPCs in adults, for example.
    Type: Application
    Filed: December 20, 2021
    Publication date: April 14, 2022
    Applicants: ABT Holding Company, AUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC.
    Inventors: Robert MAYS, Robert J. Deans, David C. Hess, James E. Carroll, Cesar V. Borlongan
  • Publication number: 20210299185
    Abstract: The invention relates to the treatment of various injuries, disorders, dysfunctions, diseases, and the like of the brain with MAPCs, particularly in some aspects, to the treatment of the same resulting from hypoxia, including that caused by systemic hypoxia and that caused by insufficient blood supply. In some further particulars the invention relates, for example, to the treatment of hypoxic ischemic brain injury with MAPCs, in children for example, and to the treatment of cortical infarcts and stroke with MAPCs in adults, for example.
    Type: Application
    Filed: June 10, 2021
    Publication date: September 30, 2021
    Applicants: ABT Holding Company, AUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC.
    Inventors: Robert W. MAYS, Robert J. DEANS, David C. HESS, James E. CARROLL, Cesar V. BORLONGAN
  • Publication number: 20200354709
    Abstract: Disclosed herein are methods for the treatment of traumatic brain injury by transplantation of cells descended from marrow adherent stem cells that express an exogenous Notch intracellular domain. The transplanted cells form a pathway along which endogenous neurogenic cells proliferate and migrate from the subventricular zone to the site of injury.
    Type: Application
    Filed: March 5, 2020
    Publication date: November 12, 2020
    Applicants: SanBio, Inc., University of South Florida
    Inventors: Cesar V. BORLONGAN, Casey C. CASE
  • Patent number: 10626389
    Abstract: Disclosed herein are methods for the treatment of traumatic brain injury by transplantation of cells descended from marrow adherent stem cells that express an exogenous Notch intracellular domain. The transplanted cells form a pathway along which endogenous neurogenic cells proliferate and migrate from the subventricular zone to the site of injury.
    Type: Grant
    Filed: February 26, 2019
    Date of Patent: April 21, 2020
    Assignees: SanBio, Inc., University of South Florida
    Inventors: Cesar V. Borlongan, Casey C. Case
  • Publication number: 20190185839
    Abstract: Disclosed herein are methods for the treatment of traumatic brain injury by transplantation of cells descended from marrow adherent stem cells that express an exogenous Notch intracellular domain. The transplanted cells form a pathway along which endogenous neurogenic cells proliferate and migrate from the subventricular zone to the site of injury.
    Type: Application
    Filed: February 26, 2019
    Publication date: June 20, 2019
    Applicants: SanBio, Inc., University of South Florida
    Inventors: Cesar V. BORLONGAN, Casey C. CASE
  • Patent number: 10117900
    Abstract: The invention relates to the treatment of various injuries, disorders, dysfunctions, diseases, and the like of the brain with MAPCs, particularly in some aspects, to the treatment of the same resulting from hypoxia, including that caused by systemic hypoxia and that caused by insufficient blood supply. In some further particulars the invention relates, for example, to the treatment of hypoxic ischemic brain injury with MAPCs, in children for example, and to the treatment of cortical infarcts and stroke with MAPCs in adults, for example.
    Type: Grant
    Filed: January 23, 2007
    Date of Patent: November 6, 2018
    Assignees: ATHERSYS, INC., Augusta University Research Institute, Inc.
    Inventors: Robert Mays, Robert J. Deans, David C. Hess, James E. Carroll, Cesar V. Borlongan
  • Publication number: 20180296609
    Abstract: The invention relates to the treatment of various injuries, disorders, dysfunctions, diseases, and the like of the brain with MAPCs, particularly in some aspects, to the treatment of the same resulting from hypoxia, including that caused by systemic hypoxia and that caused by insufficient blood supply. In some further particulars the invention relates, for example, to the treatment of hypoxic ischemic brain injury with MAPCs, in children for example, and to the treatment of cortical infarcts and stroke with MAPCs in adults, for example.
    Type: Application
    Filed: December 20, 2017
    Publication date: October 18, 2018
    Applicant: AUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC.
    Inventors: Robert MAYS, Robert J. Deans, David C. Hess, James E. Carroll, Cesar V. Borlongan
  • Publication number: 20180117093
    Abstract: The invention relates to the treatment of various injuries, disorders, dysfunctions, diseases, and the like of the brain with MAPCs, particularly in some aspects, to the treatment of the same resulting from hypoxia, including that caused by systemic hypoxia and that caused by insufficient blood supply. In some further particulars the invention relates, for example, to the treatment of hypoxic ischemic brain injury with MAPCs, in children for example, and to the treatment of cortical infarcts and stroke with MAPCs in adults, for example.
    Type: Application
    Filed: January 23, 2007
    Publication date: May 3, 2018
    Applicant: ATHERSYS, INC.
    Inventors: Robert Mays, Robert J. Deans, David C. Hess, James E. Carroll, Cesar V. Borlongan
  • Patent number: 9828593
    Abstract: Disclosed herein are methods for the treatment of traumatic brain injury by transplantation of cells descended from marrow adherent stem cells that express an exogenous Notch intracellular domain. The transplanted cells form a pathway along which endogenous neurogenic cells proliferate and migrate from the subventricular zone to the site of injury.
    Type: Grant
    Filed: March 13, 2013
    Date of Patent: November 28, 2017
    Assignees: SanBio, Inc., University of South Florida
    Inventors: Cesar V. Borlongan, Casey C. Case
  • Publication number: 20150197741
    Abstract: Disclosed herein are methods for the treatment of traumatic brain injury by transplantation of cells descended from marrow adherent stem cells that express an exogenous Notch intracellular domain. The transplanted cells form a pathway along which endogenous neurogenic cells proliferate and migrate from the subventricular zone to the site of injury.
    Type: Application
    Filed: September 18, 2014
    Publication date: July 16, 2015
    Inventors: Cesar V. Borlongan, Casey C. Case
  • Publication number: 20100310570
    Abstract: The invention relates to the treatment of various injuries, disorders, dysfunctions, diseases, and the like of the brain with MAPCs, particularly in some aspects, to the treatment of the same resulting from hypoxia, including that caused by systemic hypoxia and that caused by insufficient blood supply. In some further particulars the invention relates, for example, to the treatment of hypoxic ischemic brain injury with MAPCs, in children for example, and to the treatment of cortical infarcts and stroke with MAPCs in adults, for example.
    Type: Application
    Filed: January 23, 2007
    Publication date: December 9, 2010
    Applicant: ATHERSYS, INC.
    Inventors: Robert Mays, Robert J. Deans, David C. Hess, James E. Carroll, Cesar V. Borlongan